atrasentan has been researched along with Brain Edema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Applegate, R; Chen, W; Fathali, N; Khatibi, NH; Lee, LK; Martin, R; Rolland, W; Stier, G; Zhang, JH; Zhou, Y | 1 |
| Blezer, EL; Goldschmeding, R; Jansen, GH; Joles, JA; Koomans, HA; Nicolay, K; Rabelink, TJ | 1 |
2 other study(ies) available for atrasentan and Brain Edema
| Article | Year |
|---|---|
Endothelin receptor-A (ETa) inhibition fails to improve neonatal hypoxic-ischemic brain injury in rats.
Topics: Animals; Animals, Newborn; Atrasentan; Brain Edema; Brain Infarction; Brain Injuries; Endothelin A Receptor Antagonists; Functional Laterality; Hand Strength; Hypoxia-Ischemia, Brain; Maze Learning; Motor Activity; Psychomotor Performance; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Tetrazolium Salts | 2011 |
Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats.
Topics: Animals; Atrasentan; Blood Pressure; Brain Edema; Data Interpretation, Statistical; Endothelin Receptor Antagonists; Hypertension; Hypertension, Malignant; Kidney; Magnetic Resonance Imaging; Male; Proteinuria; Pyrrolidines; Rats; Rats, Inbred SHR; Sodium Chloride, Dietary; Stereoisomerism; Time Factors | 1999 |